Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Reading labels for certifications ensures quality
Certain Medical Conditions People with a history of conditions such as pancreatitis, severe gastrointestinal disorders, gallbladder disease, significant kidney or liver problems or certain endocrine conditions may require careful assessment before considering Retatrutide
Not many
Retatrutide is an investigational triple incretin receptor agonist (GLP-1, GIP, and glucagon) not yet approved by the MHRA or EMA
US$ 28.44
US$ 28.68
US$ 25.45
US$ 25.91
US$ 26.32
US$ 24.37
US$ 21.84
US$ 23.52
US$ 26.02
US$ 27.86
